
Led by scientists, Elcella is a company driven by curiosity to improve the lives of all people. That is why all our research is focused on humans.
Our data comes from experiments performed on gut samples from real people who, just like us, want to help others.
Elcella is proud to be a company that values science and knowledge so we can bring you the best gut health solutions.

Dr. Madusha Peiris, Founder & CEO
Dr. Madusha Peiris completed her PhD at the University of Queensland, Australia. Her passion for understanding the gut-brain connection and the important role of nutrients in appetite regulation led to groundbreaking research. Dr. Madusha's dedication to her work was instrumental in the discovery that laid the foundation for Elcella’s natural approach to appetite control and digestive well-being.

Dr. Ruby Aktar, Co-Founder & COO
Dr. Ruby Aktar completed her undergraduate studies at Queen Mary University of London, followed by a PhD in enteric neuroscience. Her research explores how gut microbes affect gut physiology, and how nutrients affect appetite regulation. Dr. Ruby is passionate about learning how to make natural supplements (like Elcella!), that manage appetite and improve overall well-being.
FAQ
Still have questions? We’re here to help! Email us at hello@elcella.com, and we’ll get back to you as soon as possible.
Who are the scientists behind Elcella?
The Elcella team comprises leading researchers in gut health, including Dr. Madusha Peiris and Dr. Ruby Aktar, who have extensive backgrounds in neurogastroenterology and appetite regulation. Their expertise drives our commitment to innovative, science-backed solutions. We also have a team of in-house scientists who are researching every. single. day.
What roles do the scientists play at Elcella?
Our scientists lead research and development, focusing on discovering and validating the best nutrients for gut health. They conduct clinical trials, analyse data, and collaborate with other institutions to ensure our products are effective and safe. They also lead the company!
What is the research process like at Elcella?
Our research process involves multiple stages, including laboratory studies, pre-clinical testing, and clinical trials with human participants. We start by identifying key nutrients, followed by rigorous testing to evaluate their effects on gut health and appetite regulation.
How do you ensure the quality and safety of your research?
We adhere to strict ethical guidelines and regulatory standards throughout our research process. Our collaborations with esteemed institutions, such as Queen Mary University of London and Barts NHS Trust, further enhance the credibility and reliability of our findings.
How does Elcella work?
Elcella’s product works by delivering a unique combination of nutrients that stimulate the gut's appetite-regulating mechanisms. By enhancing the function of L-Cells in the gut, our formulation helps promote feelings of fullness and supports natural appetite control.
What is 'Nat Tech,' and how does it relate to your products?
'Nat Tech' refers to our approach of harnessing the power of nature to develop innovative solutions for gut health. We focus on using natural ingredients and scientific research to create effective products that support your well-being.
How can I stay updated on Elcella's research and developments?
You can stay informed by subscribing to our newsletter, following us on social media, and regularly checking our website for updates on our latest research, studies, and product launches.
Our discoveries are validated by the scientific community.
The cutting-edge science behind our approach is supported by peer-reviewed studies, published in top international research journals.

British Journal of Pharmacology, 2024
GPR84 In Physiology - Many functions in many tissues

Gut, 2022
Decoy bypass for appetite suppression in obese adults: role of synergistic nutrient sensing receptors GPR84 and FFAR4 on colonic endocrine cells

Nutrients, 2018
Effect of Obesity on the Expression of Nutrient Receptors and Satiety Hormones in the Human Colon

British Journal of Pharmacology, 2012